Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1729-67-5

Post Buying Request

1729-67-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1729-67-5 Usage

Description

Methyl 2,3-dibromopropionate is the methyl ester of 2,3-dibromopropanoic acid, a chemical compound known for its reactivity and utility in the synthesis of various organic molecules.

Uses

Used in Chemical Synthesis:
Methyl 2,3-dibromopropionate is used as a synthetic intermediate for the preparation of methyl 2-azidoacrylate, which is an important compound in the synthesis of various organic molecules and pharmaceuticals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 2,3-dibromopropionate is used as a key building block for the synthesis of complex organic molecules, such as methyl (+)-(1′R, 2R) and (-)-(1′R, 2S)-1-(2-phenylethanol)aziridine-2-carboxylates. These compounds have potential applications in the development of new drugs and therapeutic agents.
Additionally, Methyl 2,3-dibromopropionate is used as a reagent in the synthesis of 2-substituted pyrido-oxazine, which is formed by its reaction with 2-acetamido-3-hydroxypyridine. Methyl 2,3-dibromopropionate may have potential applications in various fields, including pharmaceuticals and materials science.

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 1729-67-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,2 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1729-67:
(6*1)+(5*7)+(4*2)+(3*9)+(2*6)+(1*7)=95
95 % 10 = 5
So 1729-67-5 is a valid CAS Registry Number.
InChI:InChI=1/C4H6Br2O2/c1-8-4(7)3(6)2-5/h3H,2H2,1H3/t3-/m1/s1

1729-67-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2,3-dibromopropionate

1.2 Other means of identification

Product number -
Other names methyl 2,3-dibromopropanoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1729-67-5 SDS

1729-67-5Relevant articles and documents

1,2,2-Tribromocyclopropanecarboxylic acid and derivatives - Valuable intermediates for four carbon cyclopropane and cyclopropene synthons

Al Dulayymi, Ahmad R.,Al Dulayymi, Juma'a R.,Baird, Mark S.,Gerrard, Michelle E.,Koza, Gani,Harkins, Samantha D.,Roberts, Evan

, p. 3409 - 3424 (1996)

Methyl 1,1,2-tribromocyclopropanecarboxylate is readily available by dibromocyclopropanation of methyl α-bromoacrylate. Reaction with methyllithium at low temperature provides a simple route to methyl 2-bromocyclopropene carboxylate, while modification of the ester group followed by reaction with methyllithium leads to a series of related four-carbon cyclopropenes. The tribromo-ester is also readily converted into 1,1,2,2-tetrabromocyclopropane, a valuable three-carbon cyclopropene synthon.

COMPOUNDS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

-

Paragraph 0079, (2020/12/07)

This document discloses a novel class of compounds for inhibiting bacterial growth and treating bacterial infection. The compounds target a key step of the futalosine pathway and therefore are effective for the selective inhibition of certain bacterial species and genera with reduced side effect in comparison with conventional antibiotics.

Using bar infrared spectra and coincidence indexes to study the diversity of solid cyanuric acid structures

Nilo, Marcela C. B. G.,Sim?es, Thais G.,Neto, Claudio Costa

, p. 1499 - 1515 (2018/06/12)

A general method was developed for studying the diversity of individuals in a population based on the diversity of infrared spectra of solid cyanuric acid analytes obtained from various reactions of trichlorocyanuric acid. This method first generates infrared bar spectra for the analytes and then measures the coincidence and continence among pairs of the spectral peaks via confrontation matrices. Class markers are established to characterize analyte classes. Possible correlations among the employed reaction conditions and the nature of the produced solids, which are based on their infrared bar spectra, are discussed. The method of coincidence may be useful for characterizing polymorphs, particularly those of active pharmaceutical ingredients (APIs). The method may also be extended to define the homogeneity of solid analytes. The ANALIN module of the ANALOR software suite running on a dBase platform is used to generate the bar infrared spectra and to handle all calculations.

Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

van Greunen, Divan G.,Cordier, Werner,Nell, Margo,van der Westhuyzen, Chris,Steenkamp, Vanessa,Panayides, Jenny-Lee,Riley, Darren L.

, p. 671 - 690 (2017/02/10)

A series of twenty seven acetylcholinesterase inhibitors, as potential agents for the treatment of Alzheimer's disease, were designed and synthesised based upon previously unexplored chemical space surrounding the molecular skeleton of the drug donepezil, which is currently used for the management of mild to severe Alzheimer's disease. Two series of analogues were prepared, the first looking at the replacement of the piperidine ring in donepezil with different sized saturated N-containing ring systems and the second looking at the introduction of different linkers between the indanone and piperidine rings in donepezil. The most active analogue 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl 1-benzylpiperidine-4-carboxylate (67) afforded an in vitro IC50value of 0.03 ± 0.07 μM against acetylcholinesterase with no cytotoxicity observed (IC50of >100 μM, SH-SY5Y cell line). In comparison donepezil had an IC50of 0.05 ± 0.06 μM and an observed cytotoxicity IC50of 15.54 ± 1.12 μM. Molecular modelling showed a strong correlation between activity and in silico binding in the active site of acetylcholinesterase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1729-67-5